Apple Inc. (AAPL - Free Report) sold fewer iPhones in its fiscal Q2 2018: 52.2 million versus the 52.5 million expected. Earnings topped the Zacks consensus by 4 cents to $2.73 per share on $61.1 billion in sales, which was in-line with estimates. The world's biggest gadget-maker -- and Zacks Rank #4 (Sell)-rated stock ahead of the earnings report -- posted quarterly gross margin of 38.3%, and guided to a similar range for Q3: 38-38.5%.

The average selling price (ASP) for the iPhone also dropped a bit in the quarter, though overall revenues for the phone grew 14%. Apple sold 9.1 million iPads and 4.1 million Macs in the quarter, for overall sales growth of 16% year over year. The company also announced another massive share buyback program -- to the tune of $100 million -- as well as another 16% share dividend increase. Shares are still down year-to-date, but are up 4% on the earnings news. For more on AAPL's earnings, click here.

Snap Inc. (SNAP - Free Report) had a problematic quarter in its earnings report after the bell today, meeting bottom-line estimates of -17 cents per share but just $230.7 million in revenues well below the expected $246.1 million. Daily active users totaled 191 million, also beneath forecasts. The company did see total ad revenue rise 61% in the quarter, but with average revenue per user down 21% sequentially, costs per user are up. Shares are down double-digits in late afternoon trading. For more on SNAP's earnings, click here.

A tough quarter for Gilead (GILD - Free Report) was reported after Tuesday's close, with earnings of $1.48 per share well below the $1.66 expected and the year-ago number of $2.23 per share. Revenues did not fare any better, reaching just $5.09 billion from the $5.42 billion in the Zacks consensus. Guidance for Gilead's full year remained unchanged, with the Zacks consensus expecting $6.43 per share on $21.22 billion in sales prior to the earnings release.

Good news came from the company's recently acquired Kite Pharma treatment Yescarta, which blossomed to $40 million in sales from the $16 million in the previous quarter. Shares are down 5% in the after-market. For more on GILD's earnings, click here.

T-Mobile U.S. (TMUS - Free Report) , only a day removed from its long-awaited merger agreement with Sprint, posted a Q1 beat on both earnings and revenues: 78 cents per share versus 72 cents expected on $10.46 billion in sales that topped the $10.38 billion in the Zacks consensus. Net adds were also better than expected in the quarter, to 1.4 million from the 1.27 million estimated. T-Mobile hasn't missed earnings estimates since Q4 of 2015, with a trailing 4-quarter average earnings beat of 47.6%.

Wall Street’s Next Amazon

Zacks EVP Kevin Matras believes this familiar stock has only just begun its climb to become one of the greatest investments of all time. It’s a once-in-a-generation opportunity to invest in pure genius. Click for details >>

Zacks Names "Single Best Pick to Double"

From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.

It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.

This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.

Free: See Our Top Stock and 4 Runners Up >>